Lamara Kamilia Ould, Noël Nathan, Massicot Fabien, Vasse Jean-Luc, Vincent Stéphane P, Behr Jean-Bernard
Université de Reims Champagne-Ardenne, CNRS, ICMR, 51097 Reims, France.
NARILIS (Namur Research Institute for Life Sciences), UNamur, Rue de Bruxelles 61, 5000 Namur, Belgium.
Molecules. 2025 Jan 8;30(2):226. doi: 10.3390/molecules30020226.
A straightforward synthetic route towards DAB-1 scaffolded dimeric iminosugars is described here, starting from readily available bis-glycosylamines. The method allows the integration of a variety of linkages (aryl, alkyl, polyethyleneglycol chains) between both iminosugars through the choice of the bis-amine used in the first step. Moreover, an additional substituent (allyl, ethynyl) may be inserted into the structure via nucleophilic addition of an organometallic reagent to the starting bis-glycosylamine. A symmetrical ethynyl-iminosugar proved susceptible to intramolecular Glaser coupling, affording the corresponding macrocyclic structure. Dimeric iminosugars were tested towards a series of commercial glycosidases to uncover potencies and selectivities when compared to DAB-1, their monomeric counterpart. Whereas a significant drop in inhibition potencies was observed towards glucosidases, some compounds displayed unexpected potent inhibition of β-galactosidase.
本文描述了一种从容易获得的双糖基胺出发,合成以DAB-1为骨架的二聚亚氨基糖的直接合成路线。该方法通过第一步中使用的双胺的选择,能够在两个亚氨基糖之间引入多种连接基团(芳基、烷基、聚乙二醇链)。此外,通过将有机金属试剂亲核加成到起始双糖基胺上,可以在结构中引入额外的取代基(烯丙基、乙炔基)。一种对称的乙炔基亚氨基糖被证明易受分子内格拉泽偶联反应的影响,从而得到相应的大环结构。将二聚亚氨基糖针对一系列商业糖苷酶进行测试,以揭示与它们的单体对应物DAB-1相比时的活性和选择性。虽然观察到对葡萄糖苷酶的抑制活性显著下降,但一些化合物对β-半乳糖苷酶表现出意想不到的强效抑制作用。